Progress toward improving animal models for idiopathic pulmonary fibrosis

American Journal of the Medical Sciences

Volumn 341, Issue 6, 2011, Pages 444-449

  Degryse, Amber L ^a   Lawson, William E ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Affairs Medical Center   (United States)

Author keywords

Bleomycin; Bronchoalveolar stem cell; Epithelial mesenchymal transition; Idiopathic pulmonary fibrosis; Lung

Indexed keywords

ADENOVIRUS VECTOR; BLEOMYCIN; DOXYCYCLINE; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 1BETA; LENTIVIRUS VECTOR; SILICON DIOXIDE; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CONFERENCE PAPER; COUGHING; DYSPNEA; EPITHELIAL MESENCHYMAL TRANSITION; EXERCISE TOLERANCE; FIBROSING ALVEOLITIS; GENE EXPRESSION; IRRADIATION; LUNG ALVEOLUS EPITHELIUM; NICK END LABELING; NONHUMAN; SINGLE DRUG DOSE; TRANSGENIC MOUSE;

ANIMALS; BLEOMYCIN; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; IDIOPATHIC PULMONARY FIBROSIS; RADIATION INJURIES, EXPERIMENTAL; SILICON DIOXIDE;

EID: 79958137848     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31821aa000     Document Type: Conference Paper

References (32)

1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-25. (Pubitemid 32758505)
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
3. Frankel SK, Schwarz MI. Update in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2009;15:463-9.
4. American Thoracic Society/European Respiratory Society. Interna-tional Multidisciplinary Consensus Classification of the Idiopathic In-terstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
5. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:L152-60. (Pubitemid 351253350)
6. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40:362-82. (Pubitemid 351249887)
7. Muggia FM, Louie AC, Sikic BI. Pulmonary toxicity of antitumor agents. Cancer Treat Rev 1983;10:221-43. (Pubitemid 14196052)
8. Hoshino T, Okamoto M, Sakazaki Y, et al. Role ofproinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. Am J Respir Cell Mol Biol 2009;41:661-70.
9. Piguet PF, Collart MA, Grau GE, et al. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63. (Pubitemid 19226654)
10. Higashiyama H, Yoshimoto D, Okamoto Y, et al. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis. J Clin Pathol 2007;60:283-9. (Pubitemid 46447744)
11. Chung MP, Monick MM, Hamzeh NY, et al. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 2003;29:375-80. (Pubitemid 37093996)
12. Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time, and genetic strain. J Environ Pathol Toxicol Oncol 1998; 17:81-97. (Pubitemid 28168809)
13. Piguet PF, Collart MA, Grau GE, et al. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990;344:245-7.
14. Barbarin V, Nihoul A, Misson P, et al. The role of pro-and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 2005;6:112.
15. Moore BB, Murray L, Das A, et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006;35:175-81. (Pubitemid 44175316)
16. Christensen PJ, Goodman RE, Pastoriza L, et al. Induction oflung fibrosis in the mouse by intratracheal instillation of fluorescein isothio-cyanate is not T-cell-dependent. Am J Pathol 1999;155:1773-9.
17. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995;31:361-9.
18. Rube CE, Uthe D, Schmid KW, et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 2000;47:1033-42. (Pubitemid 30345604)
19. Haston CK, Travis EL. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 1997;57:5286-91. (Pubitemid 27516365)
20. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100:768-76. (Pubitemid 27371693)
21. Miyazaki Y, Araki K, Vesin C, et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 1995;96:250-9.
22. Kolb M, Margetts PJ, Anthony DC, et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001;107:1529-36. (Pubitemid 32574639)
23. Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004;200:377-89. (Pubitemid 39031256)
24. Korfhagen TR, Swantz RJ, Wert SE, et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 1994;93:1691-9. (Pubitemid 24116410)
25. Hardie WD, Le Cras TD, Jiang K, et al. Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmo-nary fibrosis. Am J Physiol Lung Cell Mol Physiol 2004;286:L741-9. (Pubitemid 38365059)
26. Lawson WE, Polosukhin VV, Zoia O, et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:899-907. (Pubitemid 40562721)
27. Lawson WE, Polosukhin VV, Stathopoulos GT, et al. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 2005;167:1267-77. (Pubitemid 41541413)
28. Tanjore H, Xu XC, Polosukhin VV, et al. Contribution ofepithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2009;180:657-65.
29. Degryse AL, Tanjore H, Xu XC, et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010;299:L442-52.
30. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-35. (Pubitemid 40806415)
31. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-5. (Pubitemid 44338936)
32. Kim KK, Wei Y, Szekeres C, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofi-broblast formation and pulmonary fibrosis. J Clin Invest 2009;119: 213-24.